Activating mutations for the Met tyrosine kinase receptor in human cancer
Recently, mutations in the Met tyrosine kinase receptor have been identified in both hereditary and sporadic forms of papillary renal carcinoma. We have introduced the corresponding mutations into the met cDNA and examined the effect of each mutation in biochemical and biological assays. We find tha...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1997
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC23495/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9326629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.94.21.11445 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|